Futura Medical plc (FUM) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 40

Futura Medical plc (FUM) - Financial and Strategic SWOT Analysis Review

Summary

Futura Medical plc. (Futura) is a publicly held pharmaceutical group primarily engaged in the development of innovative products for the consumer healthcare market specializing in sexual healthcare and pain relief management. As part of its expansion strategy, Futura is extensively working through internal product development and external product acquisitions. The company have six products in the development pipeline for sexual healthcare and pain relief management: CSD500, PET500, MED2002, TPR100, TPR100–Rx and RAD100. The company runs its development work and holds the intellectual property rights and distribution agreements through its wholly owned subsidiary Futura Medical Developments Limited. Futura Medical is headquartered in Surrey, the UK.

Futura Medical plc Key Recent Developments

Sep 08, 2010 Futura Medical Reports Net Loss Of GBP0.4 Million For H1 2010
Apr 01, 2010 Futura Medical Files For CSD500 CE Mark Approval
Apr 01, 2010 Futura Medical Submits CSD500 For CE Mark Approval
Apr 01, 2010 Csd500 Dossier Submitted For Approval
Feb 02, 2010 Csd500 Update

This comprehensive SWOT profile of Futura Medical plc provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Futura Medical plc - Key Facts
Futura Medical plc - Key Employees
Futura Medical plc - Key Employee Biographies
Futura Medical plc - Major Products and Services
Futura Medical plc - Pharmaceutical Pipeline Products Data
Futura Medical plc, Pipeline Products by Therapy Area
Futura Medical plc, Pipeline Products by Development Phase
Futura Medical plc Pipeline Products by Development Stage
Futura Medical plc - History
Futura Medical plc - Company Statement
Futura Medical plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Futura Medical plc - Business Description
Futura Medical plc - Corporate Strategy
Futura Medical plc - SWOT Analysis
SWOT Analysis - Overview
Futura Medical plc - Strengths
Strength - Strong Product Pipeline
Strength - Proprietary Delivery Technology
Strength - Partnerships and Agreements
Weakness - Higher Operating Costs affecting Margins
Weakness - Declining Liquidity
Opportunity - New Agreement with Ansell
Opportunity - Market Potential: Pain
Opportunity - Emerging Markets
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Threat - Competitive Pressure
Futura Medical plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Futura Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Futura Medical plc, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Futura Medical plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 08, 2010: Futura Medical Reports Net Loss Of GBP0.4 Million For H1 2010
Apr 01, 2010: Futura Medical Files For CSD500 CE Mark Approval
Apr 01, 2010: Futura Medical Submits CSD500 For CE Mark Approval
Apr 01, 2010: Csd500 Dossier Submitted For Approval
Feb 02, 2010: Csd500 Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Futura Medical plc, Key Facts
Futura Medical plc, Key Employees
Futura Medical plc, Key Employee Biographies
Futura Medical plc, Major Products and Services
Futura Medical plc, Number of Pipeline Products by Therapy Area
Futura Medical plc, Number of Pipeline Products by Development Stage
Futura Medical plc, Pipeline Products By Therapy Area and Development Phase
Futura Medical plc Number of Pipeline Products by Development Stage
Futura Medical plc Pipeline Products by Development Stage
Futura Medical plc, History
Futura Medical plc, Other Locations
Futura Medical plc, Subsidiaries
Futura Medical plc, Key Competitors
Futura Medical plc, Ratios based on current share price
Futura Medical plc, Annual Ratios
Futura Medical plc, Interim Ratios
Futura Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Futura Medical plc, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Futura Medical plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Futura Medical plc, Pipeline Products by Therapy Area
Futura Medical plc, Pipeline Products by Development Phase
Futura Medical plc Pipeline Products by Development Stage
Futura Medical plc, Performance Chart (2006 - 2010)
Futura Medical plc, Ratio Charts
Futura Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Futura Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011

Vernalis plc
Sinclair Pharma Plc
Renovo Group Plc
Antisoma plc
Allergy Therapeutics plc
Alliance Pharma Plc
Ardana Plc

Customers who bought this item also bought

• Logica Plc
• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Computacenter plc
• Cable&Wireless Worldwide plc
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Company Study of Shanghai Kingstar Winning Software Co., Ltd., 2011
• Company Study of Shanghai Kingstar Winning Software Co., Ltd., 2011
• Ixia - Company Analysis
• Scientific Games Corporation - Company Analysis